CVE-2015-1671

HIGHCISA KEV

7.8

Descricao

The Windows DirectWrite library, as used in Microsoft .NET Framework 3.0 SP2, 3.5, 3.5.1, 4, 4.5, 4.5.1, and 4.5.2; Office 2007 SP3 and 2010 SP2; Live Meeting 2007 Console; Lync 2010; Lync 2010 Attendee; Lync 2013 SP1; Lync Basic 2013 SP1; Silverlight 5 before 5.1.40416.00; and Silverlight 5 Developer Runtime before 5.1.40416.00, allows remote attackers to execute arbitrary code via a crafted TrueType font, aka "TrueType Font Parsing Vulnerability."

Detalhes CVE

Pontuacao CVSS v3.17.8

SeveridadeHIGH

Vetor CVSSCVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Vetor de ataqueLOCAL

ComplexidadeLOW

Privilegios necessariosNONE

Interacao do usuarioREQUIRED

Publicado5/13/2015

Ultima modificacao4/22/2026

Fontekev

Avistamentos honeypot0

CISA KEV

FornecedorMicrosoft

ProdutoWindows

Nome da vulnerabilidadeMicrosoft Windows Remote Code Execution Vulnerability

Data inclusao KEV2022-05-25

Prazo de remediacao2022-06-15

Uso em ransomwareUnknown

Produtos afetados

microsoft:.net_frameworkmicrosoft:live_meetingmicrosoft:lyncmicrosoft:silverlightmicrosoft:windows_7microsoft:windows_8microsoft:windows_8.1microsoft:windows_server_2003microsoft:windows_server_2008microsoft:windows_server_2012microsoft:windows_vista

Referencias

http://www.securityfocus.com/bid/74490(secure@microsoft.com)

http://www.securitytracker.com/id/1032281(secure@microsoft.com)

https://docs.microsoft.com/en-us/security-updates/securitybulletins/2015/ms15-044(secure@microsoft.com)

http://www.securityfocus.com/bid/74490(af854a3a-2127-422b-91ae-364da2661108)

http://www.securitytracker.com/id/1032281(af854a3a-2127-422b-91ae-364da2661108)

https://docs.microsoft.com/en-us/security-updates/securitybulletins/2015/ms15-044(af854a3a-2127-422b-91ae-364da2661108)

https://www.cisa.gov/known-exploited-vulnerabilities-catalog?field_cve=CVE-2015-1671(134c704f-9b21-4f2e-91b3-4a467353bcc0)

Correlacoes IOC

Sem correlacoes registradas

This product uses data from the NVD API but is not endorsed or certified by the NVD.